Diluted EPS came in at $-0.30 (+48.3% YoY).
Trailing eight quarters through Q1 2025
Common questions about Edesa Biotech, Inc.'s Q1 2025 earnings report.
Edesa Biotech, Inc. (EDSA) reported Q1 2025 earnings on May 14, 2025 before market open.
Edesa Biotech, Inc. reported diluted EPS of $-0.30 for Q1 2025.
EPS beat the consensus estimate of $-0.30 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 48.3% from $-0.58.
You can read the 10-Q periodic report (0001171843-25-003189) directly on SEC EDGAR. The filing index links above go to sec.gov.